ADRB3 and neoplasm: The selective β3-AR antagonism on TILs rendered, indeed, these cells inefficient in inducing the PD-L1 expression on NB tumor cells due to an altered secretion of IFN-γ, and preventing de facto the establishment of an adaptive immune resistance.